People News

Share this article:

Cambridge, MA-based biotech Achemix Corp. appointed Ken Bate to president and chief executive officer. Duncan Higgons, currently president and CEO, has accepted a position at another biotech, and will leave Achemix. Bate was previously president and CEO at NitroMed. Prior to that, he served as EVP, head of commercial operations and CFO at Millennium Pharmaceuticals.

 

Vertex Pharmaceuticals promoted Peter Mueller to EVP, global R&D chief and chief science officer. The promotion follows Freda Lewis-Hall's move from Vertex to Pfizer. Mueller was previously Vertex's EVP, drug innovation and realization, and chief scientific officer. Prior to Vertex, Mueller was SVP of R&D at Boehringer Ingelheim.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media